326030.KS PE Benchmarks

SK Biopharmaceuticals Co., Ltd. • Healthcare

PE Type:

Period:

Data Quality:Good

Current PE Ratio

26.3

Diluted • annual

Forward PE

23.7

NTM Estimate

Sector Companies

500

310 with PE data

Sector Median PE

75.4

310 companies

Peer Companies

Direct competitors

Sector Analysis: Healthcare

Total Companies

500

With PE Data

310

Median PE

75.4

PE Range

0.8 - 198.6

Forward PE Median

21.2

Healthcare Sector

2914 companies • sector

Above Median(55th %ile)

Current PE:26.3

Forward PE:23.7

Median PE:22.2

Average PE:35.1

Min PE:0.1

Max PE:198.8

25th-75th %ile:10.7 - 43.4

Min: 0.1Max: 198.8

Current: 26.3

Biotechnology Industry

617 companies • industry

Above Median(54th %ile)

Current PE:26.3

Forward PE:23.7

Median PE:21.6

Average PE:37.0

Min PE:0.1

Max PE:198.1

25th-75th %ile:6.6 - 49.6

Min: 0.1Max: 198.1

Current: 26.3

Peer Companies

5 companies • peers

Low PE(25th %ile)

Current PE:26.3

Forward PE:23.7

Median PE:43.9

Average PE:46.3

Min PE:40.8

Max PE:57.2

25th-75th %ile:43.2 - 46.2

Min: 40.8Max: 57.2

Current: 26.3

KR Market

1248 companies • country

Above Median(67th %ile)

Current PE:26.3

Forward PE:23.7

Median PE:14.3

Average PE:28.4

Min PE:0.1

Max PE:197.4

25th-75th %ile:7.0 - 32.4

Min: 0.1Max: 197.4

Current: 26.3

Peer Companies

(5 companies)

068270.KS

302440.KS

207940.KS

000100.KS

035720.KS

Stock List PE Comparison

No stock lists found. Create one in Stock Lists.

About PE Benchmarks

• Sector: Companies in the same broad industry sector
• Industry: Companies in the same specific industry classification
• Peers: Direct competitors identified through business analysis
• Position: Where this stock ranks relative to the benchmark group
• Forward PE: Based on next 4 quarters analyst EPS estimates from earnings data

Last updated: 6/17/2026, 9:19:01 AM• Based on latest annual diluted PE ratios

326030.KS PE Benchmarks

SK Biopharmaceuticals Co., Ltd. • Healthcare

PE Type:

Period:

Data Quality:Good

Current PE Ratio

26.3

Diluted • annual

Forward PE

23.7

NTM Estimate

Sector Companies

500

310 with PE data

Sector Median PE

75.4

310 companies

Peer Companies

Direct competitors

Sector Analysis: Healthcare

Total Companies

500

With PE Data

310

Median PE

75.4

PE Range

0.8 - 198.6

Forward PE Median

21.2

Healthcare Sector

2914 companies • sector

Above Median(55th %ile)

Current PE:26.3

Forward PE:23.7

Median PE:22.2

Average PE:35.1

Min PE:0.1

Max PE:198.8

25th-75th %ile:10.7 - 43.4

Min: 0.1Max: 198.8

Current: 26.3

Biotechnology Industry

617 companies • industry

Above Median(54th %ile)

Current PE:26.3

Forward PE:23.7

Median PE:21.6

Average PE:37.0

Min PE:0.1

Max PE:198.1

25th-75th %ile:6.6 - 49.6

Min: 0.1Max: 198.1

Current: 26.3

Peer Companies

5 companies • peers

Low PE(25th %ile)

Current PE:26.3

Forward PE:23.7

Median PE:43.9

Average PE:46.3

Min PE:40.8

Max PE:57.2

25th-75th %ile:43.2 - 46.2

Min: 40.8Max: 57.2

Current: 26.3

KR Market

1248 companies • country

Above Median(67th %ile)

Current PE:26.3

Forward PE:23.7

Median PE:14.3

Average PE:28.4

Min PE:0.1

Max PE:197.4

25th-75th %ile:7.0 - 32.4

Min: 0.1Max: 197.4

Current: 26.3

Peer Companies

(5 companies)

068270.KS

302440.KS

207940.KS

000100.KS

035720.KS

Stock List PE Comparison

No stock lists found. Create one in Stock Lists.

About PE Benchmarks

• Sector: Companies in the same broad industry sector
• Industry: Companies in the same specific industry classification
• Peers: Direct competitors identified through business analysis
• Position: Where this stock ranks relative to the benchmark group
• Forward PE: Based on next 4 quarters analyst EPS estimates from earnings data

Last updated: 6/17/2026, 9:19:01 AM• Based on latest annual diluted PE ratios